Diagnostic News and Research

RSS

ASIPP announces educational campaign to improve chronic pain patients’ quality of life

In recognition of September's designation as National Pain Awareness Month, the American Society of Interventional Pain Physicians (ASIPP) today announced that it is planning a month-long educational campaign to improve the quality of life for the approximately 75 million Americans suffering from acute and chronic pain.

3 Sep 2010

New TB diagnostic test effective in first large-scale field trial

Research assessing the effectiveness of a new diagnostic test for the detection of tuberculosis (TB) is featured in the Sept. 1 edition of the New England Journal of Medicine.

3 Sep 2010

Studies show diagnostic errors cause adverse events than medication errors

Studies show that diagnostic errors cause twice as many adverse events as medication errors, but the subject has received little attention; Pennsylvania Patient Safety Authority reviews 100 events related to diagnostic error.

3 Sep 2010

Radisphere enters partnerships with Hilton Head Hospital and East Cooper Medical Center

Radisphere National Radiology Group, a leading, national full-service radiology interpretations provider, has secured agreements with two Tenet Healthcare facilities - Hilton Head Hospital of Hilton Head, SC and East Cooper Medical Center of Mt. Pleasant, SC - to provide a combination of on-site and remote interpretation services as well as full night-time radiology coverage, all with final interpretations. Services have already been deployed at Hilton Head with East Cooper starting this week.

2 Sep 2010

Asuragen launches KRAS, BRAF mutational testing in CLIA laboratory

Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced today that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory.

2 Sep 2010

InfraReDx receives 510(k) clearance to market LipiScan IVUS Coronary Imaging System

InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the LipiScan IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound and near-infrared spectroscopy to help cardiologists identify and characterize the plaques that complicate stenting and are associated with acute coronary events.

2 Sep 2010

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.

2 Sep 2010

Laboratoires Thea acquires Mydriasert ophthalmic insert for cataract surgery

Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.

2 Sep 2010

ESC releases new Clinical Practice Guidelines for management of Grown-up Congenital Heart Disease

The European Society of Cardiology (ESC) today announces the release of new Clinical Practice Guidelines covering the management of Grown-up Congenital Heart Disease (GUCH). More than two million adults in Europe are assumed to be affected by the condition, and the numbers are growing as a consequence of sharply increased survival rates due to advances in paediatric cardiology and heart surgery.

2 Sep 2010

Quidel's RapidVue hCG lateral flow pregnancy immunoassay granted FDA 510(k) clearance

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of Quidel's RapidVue® hCG test, a lateral flow pregnancy immunoassay for the qualitative detection of human Chorionic Gonadotropin (hCG).

2 Sep 2010

Prometheus launches Crohn's Prognostic test

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This novel and unique diagnostic represents a significant advance in the Prometheus Inflammatory Bowel Disease (IBD) franchise of diagnostic and prognostic tests, and complements the market-leading PROMETHEUS® IBD Serology 7.

2 Sep 2010

GP training may accelerate improvement in physical functioning for patients with somatoform disorder

In this pragmatic cluster-randomised controlled trial the investigators aimed to test the effect of a training programme for general practitioners (GPs) in the treatment of functional somatic symptoms (FSS). Results indicate that GP training may accelerate improvement in physical functioning for patients with somatoform disorder. However, the effect is small and may not be clinically significant.

31 Aug 2010

Seredor acquires South Florida-based operator of sleep diagnostic centers

Continucare Corporation announced today that its wholly owned subsidiary Seredor Corporation has expanded its sleep center operations through the acquisition of a South Florida-based operator of sleep diagnostic centers. The acquired business currently operates two independent diagnostic testing facilities.

31 Aug 2010

EDIMS licenses First DataBank's National Drug Data File Plus database

First DataBank, a leading provider of drug databases that help drive patient safety, and EDIMS, a leading provider of interoperable emergency department (ED) information management systems, today announced they have licensed First DataBank's National Drug Data File (NDDF) Plus™ database to offer hospitals greater choice in trusted third-party drug database information to use and integrate with EDIMS ED electronic health record (EHR).

31 Aug 2010

Personal listening devices can impair hearing: Study

Personal listening devices like iPods have become increasingly popular among young and not so young people in recent years. But music played through headphones too loud or too long might pose a significant risk to hearing, according to a 24-year study of adolescent girls.

31 Aug 2010

MRI recordings at one fiftieth of a second

"Please hold absolutely still": This instruction is crucial for patients being examined by magnetic resonance imaging (MRI). It is the only way to obtain clear images for diagnosis. Up to now, it was therefore almost impossible to image moving organs using MRI. Max Planck researchers from G-ttingen have now succeeded in significantly reducing the time required for recording images - to just one fiftieth of a second.

30 Aug 2010

Biomagnetics to acquire Lanzhou New Sunshine Plastics Industry

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics' common shares.

30 Aug 2010

XIFIN ranked #1,447th on Inc. 5000 list of fastest-growing private companies

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.

30 Aug 2010

AMA supports recommended medical loss ratio rules

The American Medical Association and state medical societies are supporting a proposal by the National Association of Insurance Commissioners on what expenditures insurers can consider medical spending under the new health law.

30 Aug 2010

Lineagen completes $10.8 million Series A financing

Lineagen, Inc., a developer of innovative genomic tests and services for the screening, evaluation and diagnosis of complex disorders and diseases including autism spectrum disorders and others, today announced that PrairieGold Venture Partners has joined Lineagen's existing institutional venture investors in a further $5 million closing of its Series A round, which completes Lineagen's $10.8 million Series A financing.

30 Aug 2010